Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 30, 2025
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $2 as of January 7, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
2.00
Enterprise Value
13.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 2.00, a decrease of -100.00%. That is a compound annual growth rate of -96.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.00 | -100.00% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |